Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000882796-03-000001
Filing Date
2003-08-05
Accepted
2003-08-05 17:26:04
Documents
1
Period of Report
2003-08-04

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 5207
  Complete submission text file 0000882796-03-000001.txt   7051
Mailing Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244
Business Address 2190 PKWY LAKE DR BIRMINGHAM AL 35244 2054444600
BIOCRYST PHARMACEUTICALS INC (Issuer) CIK: 0000882796 (see all company filings)

EIN.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 1510 STICKNEY POINT RD SARASOTA FL 34231
Business Address 1510 STICKNEY POINT RD SARASOTA FL 34231 9419268223
SHERRILL JOSEPH H JR (Reporting) CIK: 0001095864 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-23186 | Film No.: 03824517